French cosmetics giant L’Oréal announced on Monday, December 8, that it has acquired an additional 10% stake in the Swiss dermatology company Galderma — owner of brands such as Alastin, Cetaphil, and Differin — bringing its total ownership to 20%.
The amount of the acquisition, which was made from a consortium led by EQT comprising Sunshine SwissCo GmbH (SSCO), Abu Dhabi Investment Authority (ADIA), and Auba Investment Pte. Ltd, has not been disclosed.
L’Oréal “will continue to support…
L’Oréal doubles its stake in Swiss laboratory Galderma
I